Name: Tango Therapeutics, Inc. (TNGX) Balance Sheet
Creator: FinSpry

Tango Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Tango Therapeutics, Inc. (TNGX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	69.53	336.89	59.97	485.26	28.38
Short-Term Investments	188.39	270.50	306.17	342.51	161.94
Cash & Short-Term Investments	257.92	336.89	366.13	485.26	190.32
Accounts Receivable	0.00	0.00	2.00	2.00	2.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	8.43	8.80	6.57	4.52	1.31
Total Current Assets	266.34	346.54	375.27	492.34	193.63
Non-Current Assets
Property, Plant & Equipment (Net)	47.58	53.42	57.77	6.09	11.30
Other Non-Current Assets	2.57	2.61	3.43	1.73	2.32
Total Non-Current Assets	50.15	56.03	61.20	7.82	0.00
Total Assets	316.49	402.57	436.47	500.16	207.25
Current Liabilities
Accounts Payable	1.60	2.79	4.45	3.28	1.84
Short-Term Debt	2.45	0.00	0.00	0.00	0.00
Accrued Liabilities	14.76	14.11	16.23	9.22	5.35
Deferred Revenue	17.62	25.67	31.79	26.02	31.98
Other Current Liabilities	1.74	15.40	1.27	9.89	0.79
Total Current Liabilities	38.17	45.94	55.55	40.69	40.92
Non-Current Liabilities
Long-Term Debt	34.04	36.84	39.36	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.01
Total Non-Current Liabilities	78.81	103.52	131.45	114.72	0.00
Total Liabilities	116.98	149.46	186.99	155.41	168.65
Stockholders' Equity
Common Stock	0.11	0.10	0.09	0.09	0.04
Retained Earnings	-501.56	-371.07	-269.51	-162.10	-103.10
Accumulated Other Comprehensive Income	0.34	0.19	-3.71	-0.77	0.02
Additional Paid-in Capital	700.63	624.08	522.61	506.76	0.00
Shares Outstanding	107.73	102.20	88.18	87.60	0.00
Total Stockholders' Equity	199.52	253.11	249.48	344.75	38.60
Total Liabilities & Equity	316.49	402.57	436.47	500.16	0.00